1-13 of 13
Cornelis J.A. Punt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells

Iris van 't Erve, Jamie E. Medina, Alessandro Leal, Eniko Papp, Jillian Phallen, Vilmos Adleff, Elaine Jiayuee Chiao, Adith S. Arun, Karen Bolhuis, John K. Simmons, Aanavi Karandikar, Kenneth C. Valkenburg, Mark Sausen, Samuel V. Angiuoli, Robert B. Scharpf, Cornelis J.A. Punt, Gerrit A. Meijer, Victor E. Velculescu, Remond J.A. Fijneman
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (5): 899–909.
https://doi.org/10.1158/1078-0432.CCR-22-2538
Published: 01 March 2023
View articletitled, Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
Open the PDF for Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells in another window
Includes: Supplementary data
Journal Articles

Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework

Ida Netterberg, Mats O. Karlsson, Leon W.M.M. Terstappen, Miriam Koopman, Cornelis J.A. Punt, Lena E. Friberg
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18): 4892–4900.
https://doi.org/10.1158/1078-0432.CCR-19-2570
Published: 15 September 2020
View articletitled, Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework
Open the PDF for Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework in another window
Includes: Supplementary data
Journal Articles

WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy

Linda J.W. Bosch, Yanxin Luo, Victoria V. Lao, Petur Snaebjornsson, Geert Trooskens, Ilse Vlassenbroeck, Sandra Mongera, Weiliang Tang, Piri Welcsh, James G. Herman, Miriam Koopman, Iris D. Nagtegaal, Cornelis J.A. Punt, Wim van Criekinge, Gerrit A. Meijer, Raymond J. Monnat, Jr, Beatriz Carvalho, William M. Grady
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (18): 4612–4622.
https://doi.org/10.1158/1078-0432.CCR-15-2703
Published: 15 September 2016
View articletitled, WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
Open the PDF for WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy in another window
Includes: Supplementary data
Journal Articles

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp, Florian Wimmers, Erik H.J.G. Aarntzen, Tjitske Duiveman-de Boer, Mandy W.M.M. van de Rakt, Nicole M. Scharenborg, Annemiek J. de Boer, Jeanette M. Pots, Michel A.M. Olde Nordkamp, Tom G.M. van Oorschot, Jurjen Tel, Gregor Winkels, Katja Petry, Willeke A.M. Blokx, Michelle M. van Rossum, Marieke E.B. Welzen, Roel D.M. Mus, Sandra A.J. Croockewit, Rutger H.T. Koornstra, Joannes F.M. Jacobs, Sander Kelderman, Christian U. Blank, Winald R. Gerritsen, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (9): 2155–2166.
https://doi.org/10.1158/1078-0432.CCR-15-2205
Published: 01 May 2016
View articletitled, Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
Open the PDF for Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells in another window
Includes: Supplementary data
Journal Articles

Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

Marc Peeters, Kelly S. Oliner, Timothy J. Price, Andrés Cervantes, Alberto F. Sobrero, Michel Ducreux, Yevhen Hotko, Thierry André, Emily Chan, Florian Lordick, Cornelis J.A. Punt, Andrew H. Strickland, Gregory Wilson, Tudor E. Ciuleanu, Laslo Roman, Eric Van Cutsem, Pei He, Hua Yu, Reija Koukakis, Jan-Henrik Terwey, Andre S. Jung, Roger Sidhu, Scott D. Patterson
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5469–5479.
https://doi.org/10.1158/1078-0432.CCR-15-0526
Published: 14 December 2015
View articletitled, Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer
Open the PDF for Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

Sabine Venderbosch, Iris D. Nagtegaal, Tim S. Maughan, Christopher G. Smith, Jeremy P. Cheadle, David Fisher, Richard Kaplan, Philip Quirke, Matthew T. Seymour, Susan D. Richman, Gerrit A. Meijer, Bauke Ylstra, Danielle A.M. Heideman, Anton F.J. de Haan, Cornelis J.A. Punt, Miriam Koopman
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (20): 5322–5330.
https://doi.org/10.1158/1078-0432.CCR-14-0332
Published: 14 October 2014
View articletitled, Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
Open the PDF for Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies in another window
Includes: Supplementary data
Journal Articles

Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, Annechien J.A. Lambeck, Erik H.J.G. Aarntzen, Joannes F.M. Jacobs, Nicole M. Scharenborg, Mandy W.M.M. van de Rakt, Annemiek J. de Boer, Sandra Croockewit, Michelle M. van Rossum, Roel Mus, Wim J.G. Oyen, Otto C. Boerman, Sophie Lucas, Gosse J. Adema, Cornelis J.A. Punt, Carl G. Figdor
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5725–5735.
https://doi.org/10.1158/1078-0432.CCR-11-1261
Published: 01 September 2011
View articletitled, Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
Open the PDF for Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients in another window
Includes: Supplementary data
Journal Articles

Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination

Sasja F. Mulder, Joannes F.M. Jacobs, Michel A.M. Olde Nordkamp, Joep M.D. Galama, Ingrid M.E. Desar, Ruurd Torensma, Steven Teerenstra, Peter F.A. Mulders, Kris C.P. Vissers, Cornelis J.A. Punt, I. Jolanda M. de Vries, Carla M.L. van Herpen
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4541–4549.
https://doi.org/10.1158/1078-0432.CCR-11-0253
Published: 05 July 2011
View articletitled, Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination
Open the PDF for Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination in another window
Includes: Supplementary data
Journal Articles

Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer

Maarten J. Deenen, Jolien Tol, Artur M Burylo, Valerie D. Doodeman, Anthonius de Boer, Andrew Vincent, Henk-Jan Guchelaar, Paul H.M. Smits, Jos H. Beijnen, Cornelis J.A. Punt, Jan H.M. Schellens, Annemieke Cats
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3455–3468.
https://doi.org/10.1158/1078-0432.CCR-10-2209
Published: 15 May 2011
View articletitled, Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer
Open the PDF for Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents

I. Jolanda M. de Vries, Chiara Castelli, Caroline Huygens, Joannes F.M. Jacobs, Julie Stockis, Beatrice Schuler-Thurner, Gosse J. Adema, Cornelis J.A. Punt, Licia Rivoltini, Gerold Schuler, Pierre G. Coulie, Sophie Lucas
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 841–848.
https://doi.org/10.1158/1078-0432.CCR-10-2227
Published: 15 February 2011
View articletitled, Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents
Open the PDF for Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents in another window
Includes: Supplementary data
Journal Articles

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

Joannes F.M. Jacobs, Cornelis J.A. Punt, W. Joost Lesterhuis, Roger P.M. Sutmuller, H. Mary-lène H. Brouwer, Nicole M. Scharenborg, Ina S. Klasen, Luuk B. Hilbrands, Carl G. Figdor, I. Jolanda M. de Vries, Gosse J. Adema
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (20): 5067–5078.
https://doi.org/10.1158/1078-0432.CCR-10-1757
Published: 13 October 2010
View articletitled, Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
Open the PDF for Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients in another window
Journal Articles

Phase I Clinical and Magnetic Resonance Imaging Study of the Vascular Agent NGR-hTNF in Patients with Advanced Cancers (European Organization for Research and Treatment of Cancer Study 16041)

Hanneke W.M. van Laarhoven, Walter Fiedler, Ingrid M.E. Desar, Jack J.A. van Asten, Sandrine Marréaud, Denis Lacombe, Anne-Sophie Govaerts, Jan Bogaerts, Peter Lasch, Johanna N.H. Timmer-Bonte, Antonio Lambiase, Claudio Bordignon, Cornelis J.A. Punt, Arend Heerschap, Carla M.L. van Herpen
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (4): 1315–1323.
https://doi.org/10.1158/1078-0432.CCR-09-1621
Published: 15 February 2010
View articletitled, Phase I Clinical and Magnetic Resonance Imaging Study of the Vascular Agent NGR-hTNF in Patients with Advanced Cancers (European Organization for Research and Treatment of Cancer Study 16041)
Open the PDF for Phase I Clinical and Magnetic Resonance Imaging Study of the Vascular Agent NGR-hTNF in Patients with Advanced Cancers (European Organization for Research and Treatment of Cancer Study 16041) in another window
Journal Articles

Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients

Pauline Verdijk, Erik H.J.G. Aarntzen, W. Joost Lesterhuis, A.C. Inge Boullart, Ellemieke Kok, Michelle M. van Rossum, Simon Strijk, Femke Eijckeler, Johannes J. Bonenkamp, Joannes F.M. Jacobs, Willeke Blokx, J. Han J.M. vanKrieken, Irma Joosten, Otto C. Boerman, Wim J.G. Oyen, Gosse Adema, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2531–2540.
https://doi.org/10.1158/1078-0432.CCR-08-2729
Published: 01 April 2009
View articletitled, Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Open the PDF for Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients in another window